Małgorzata Czyż (Malgorzata Czyz, Małgorzata Czyz)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 30

Top Venues

International journal of molecular sciences

Genes

Cancers

Apoptosis : an international journal on programmed cell death

Medical University in Lodz

Medical Academy in Lodz (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Medical University in Lodz

Poland

full professor :: Department of Molecular Biology of Cancer

Medical University in Lodz

Poland

head :: Department of Molecular Biology of Cancer

Medical University in Lodz

Poland

Associate Professor :: Department of Medicinal Chemistry

Japanese Society for Promotion of Science

Japan

fellow :: Laboratory of Prof. Kunio Yagi

Vienna International Research Cooperation Center

Austria

postdoctoral fellow :: Department for Transplantation Immunology

University of Kentucky

United States

Postdoctoral fellow :: Department of Biochemistry

Medical Academy in Lodz

Poland

assistant professor :: Department of General Chemistry

Education History

Medical Academy in Lodz

Poland

PHD

Publications

Paulina Koziej, Katarzyna Kluszczyńska, Mariusz L Hartman, Małgorzata Czyż
Trametinib-Resistant Melanoma Cells Displaying MITF high /NGFR low /IL-8 low Phenotype Are Highly Responsive to Alternating Periods of Drug Withdrawal and Drug Rechallenge. International journal of molecular sciences 24 (9) (2023)
Malgorzata Drzewiecka, Anna Gajos-Michniewicz, Grażyna Hoser, Dominika Jaśniak, Gabriela Barszczewska-Pietraszek, Przemysław Sitarek, Piotr Lech Czarny, Janusz Piekarski, Maciej Radek, Małgorzata Czyż, Tomasz Skorski, Tomasz Sliwiński
Histone Deacetylases (HDAC) Inhibitor-Valproic Acid Sensitizes Human Melanoma Cells to Dacarbazine and PARP Inhibitor. Genes 14 (6) (2023)
Katarzyna Kluszczyńska, Małgorzata Czyż
Extracellular Vesicles-Based Cell-Cell Communication in Melanoma: New Perspectives in Diagnostics and Therapy. International journal of molecular sciences 24 (2) (2023)
Katarzyna Kluszczyńska, Małgorzata Czyż
Extracellular Vesicles-Based Cell-Cell Communication in Melanoma: New Perspectives in Diagnostics and Therapy. International journal of molecular sciences 24 (2) (2023)
Malgorzata Drzewiecka, Anna Gajos-Michniewicz, Grażyna Hoser, Dominika Jaśniak, Gabriela Barszczewska-Pietraszek, Przemysław Sitarek, Piotr Lech Czarny, Janusz Piekarski, Maciej Radek, Małgorzata Czyż, Tomasz Skorski, Tomasz Sliwiński
Histone Deacetylases (HDAC) Inhibitor-Valproic Acid Sensitizes Human Melanoma Cells to Dacarbazine and PARP Inhibitor. Genes 14 (6) (2023)
Katarzyna Kluszczyńska, Małgorzata Czyż
Extracellular Vesicles-Based Cell-Cell Communication in Melanoma: New Perspectives in Diagnostics and Therapy. International journal of molecular sciences 24 (2) (2023)
Mariusz L Hartman, Małgorzata Czyż
BCL-G: 20 years of research on a non-typical protein from the BCL-2 family. Cell death and differentiation (2023)
Paulina Koziej, Katarzyna Kluszczyńska, Mariusz L Hartman, Małgorzata Czyż
Trametinib-Resistant Melanoma Cells Displaying MITF high /NGFR low /IL-8 low Phenotype Are Highly Responsive to Alternating Periods of Drug Withdrawal and Drug Rechallenge. International journal of molecular sciences 24 (9) (2023)
Malgorzata Drzewiecka, Anna Gajos-Michniewicz, Grażyna Hoser, Dominika Jaśniak, Gabriela Barszczewska-Pietraszek, Przemysław Sitarek, Piotr Lech Czarny, Janusz Piekarski, Maciej Radek, Małgorzata Czyż, Tomasz Skorski, Tomasz Sliwiński
Histone Deacetylases (HDAC) Inhibitor-Valproic Acid Sensitizes Human Melanoma Cells to Dacarbazine and PARP Inhibitor. Genes 14 (6) (2023)
Katarzyna Kluszczyńska, Małgorzata Czyż
Extracellular Vesicles-Based Cell-Cell Communication in Melanoma: New Perspectives in Diagnostics and Therapy. International journal of molecular sciences 24 (2) (2023)
Mariusz L Hartman, Paulina Koziej, Katarzyna Kluszczyńska, Małgorzata Czyż
Pro-Apoptotic Activity of MCL-1 Inhibitor in Trametinib-Resistant Melanoma Cells Depends on Their Phenotypes and Is Modulated by Reversible Alterations Induced by Trametinib Withdrawal. Cancers 15 (19) (2023)
Joanna Bojarska, Martin Breza, Milan Remko, Małgorzata Czyż, Anna Gajos-Michniewicz, Michał Zimecki, Krzysztof Kaczmarek, Izabela D Madura, Jakub M Wojciechowski, Wojciech M Wolf
Structural and Biofunctional Insights into the Cyclo(Pro-Pro-Phe-Phe-) Scaffold from Experimental and In Silico Studies: Melanoma and Beyond. International journal of molecular sciences 23 (13) (2022)
Michal Wozniak, Małgorzata Czyż
The Functional Role of Long Non-Coding RNAs in Melanoma. Cancers 13 (19) (2021)
Ewelina Madej, Damian Ryszawy, Anna A Brożyna, Małgorzata Czyż, Jarosław Czyż, Agnieszka Wolnicka-Glubisz
Deciphering the Functional Role of RIPK4 in Melanoma. International journal of molecular sciences 22 (21) (2021)
Mariusz L Hartman, Małgorzata Czyż
BCL-w: apoptotic and non-apoptotic role in health and disease. Cell death & disease 11 (4) (2020)
Marta Osrodek, Michal Rozanski, Małgorzata Czyż
Insulin Reduces the Efficacy of Vemurafenib and Trametinib in Melanoma Cells. Cancer management and research 12 (2020)
Mariusz L Hartman, Magdalena Rogut, Aleksandra Mielczarek-Lewandowska, Michal Wozniak, Małgorzata Czyż
17-Aminogeldanamycin Inhibits Constitutive Nuclear Factor-Kappa B (NF-κB) Activity in Patient-Derived Melanoma Cell Lines. International journal of molecular sciences 21 (11) (2020)
Mariusz L Hartman, Malgorzata Sztiller-Sikorska, Anna Gajos-Michniewicz, Małgorzata Czyż
Dissecting Mechanisms of Melanoma Resistance to BRAF and MEK Inhibitors Revealed Genetic and Non-Genetic Patient- and Drug-Specific Alterations and Remarkable Phenotypic Plasticity. Cells 9 (1) (2020)
Aleksandra Mielczarek-Lewandowska, Mariusz L Hartman, Małgorzata Czyż
Inhibitors of HSP90 in melanoma. Apoptosis : an international journal on programmed cell death 25 (1-2) (2020)
Malgorzata Sztiller-Sikorska, Małgorzata Czyż
Parthenolide as Cooperating Agent for Anti-Cancer Treatment of Various Malignancies. Pharmaceuticals (Basel, Switzerland) 13 (8) (2020)
Aleksandra Mielczarek-Lewandowska, Malgorzata Sztiller-Sikorska, Marta Osrodek, Małgorzata Czyż, Mariusz L Hartman
17-Aminogeldanamycin selectively diminishes IRE1α-XBP1s pathway activity and cooperatively induces apoptosis with MEK1/2 and BRAFV600E inhibitors in melanoma cells of different genetic subtypes. Apoptosis : an international journal on programmed cell death 24 (7-8) (2020)
Anna Gajos-Michniewicz, Małgorzata Czyż
WNT Signaling in Melanoma. International journal of molecular sciences 21 (14) (2020)
Marta Osrodek, Mariusz L Hartman, Małgorzata Czyż
Physiologically Relevant Oxygen Concentration (6% O2) as an Important Component of the Microenvironment Impacting Melanoma Phenotype and Melanoma Response to Targeted Therapeutics In Vitro. International journal of molecular sciences 20 (17) (2019)
Markus Düchler, Liliana Czernek, Lukasz Peczek, Wojciech Cypryk, Malgorzata Sztiller-Sikorska, Małgorzata Czyż
Melanoma-Derived Extracellular Vesicles Bear the Potential for the Induction of Antigen-Specific Tolerance. Cells 8 (7) (2019)
Małgorzata Czyż, Malgorzata Sztiller-Sikorska, Anna Gajos-Michniewicz, Marta Osrodek, Mariusz L Hartman
Plasticity of Drug-Naïve and Vemurafenib- or Trametinib-Resistant Melanoma Cells in Execution of Differentiation/Pigmentation Program. Journal of oncology 2019 (2019)
Mariusz L Hartman, Malgorzata Sztiller-Sikorska, Małgorzata Czyż
Whole-exome sequencing reveals novel genetic variants associated with diverse phenotypes of melanoma cells. Molecular carcinogenesis 58 (4) (2019)
Mariusz L Hartman, Małgorzata Czyż
TYRP1 mRNA level is stable and MITF-M-independent in drug-naïve, vemurafenib- and trametinib-resistant BRAFV600E melanoma cells. Archives of dermatological research 312 (5) (2019)
Anna Gajos-Michniewicz, Małgorzata Czyż
Role of miRNAs in Melanoma Metastasis. Cancers 11 (3) (2019)
Małgorzata Czyż
HGF/c-MET Signaling in Melanocytes and Melanoma. International journal of molecular sciences 19 (12) (2018)
Izabela Zalesna, Marta Osrodek, Mariusz L Hartman, Michal Rozanski, Malgorzata Sztiller-Sikorska, Karolina Niewinna, Dariusz Nejc, Małgorzata Czyż
Exogenous growth factors bFGF, EGF and HGF do not influence viability and phenotype of V600EBRAF melanoma cells and their response to vemurafenib and trametinib in vitro. PloS one 12 (8) (2017)

Małgorzata Czyż.css-eqlu8i{font-size:small;padding-left:4px;} (Malgorzata Czyz, Małgorzata Czyz)

Publication Activity (10 Years)

Top Topics

Top Venues

Małgorzata Czyż (Malgorzata Czyz, Małgorzata Czyz)